Royal Bank Of Canada Molecular Partners Ag Transaction History
Royal Bank Of Canada
- $425 Billion
- Q2 2024
Shares
2 transactions
Others Institutions Holding MOLN
# of Institutions
9Shares Held
860KCall Options Held
0Put Options Held
0-
Bvf Inc San Francisco, CA443KShares$2.26 Million0.1% of portfolio
-
Suvretta Capital Management, LLC New York, NY400KShares$2.04 Million0.12% of portfolio
-
Old Mission Capital LLC10.4KShares$52,7570.0% of portfolio
-
Ubs Group Ag3.46KShares$17,6160.0% of portfolio
-
Tang Capital Management LLC San Diego, CA2.5KShares$12,7250.0% of portfolio
About MOLECULAR PARTNERS AG
- Ticker MOLN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 32,514,000
- Market Cap $165M
- Description
- Molecular Partners AG operates as a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic proteins. Its products candidates include Abicipar, a DARPin therapeutic candidate, which is in Phase III clinical trials for the treatment of neovascular wet age-related macular degeneration, ...